Filing Details

Accession Number:
0000899243-21-045409
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-19 17:15:55
Reporting Period:
2021-11-17
Accepted Time:
2021-11-19 17:15:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588972 Recro Pharma Inc. REPH Pharmaceutical Preparations (2834) 261523233
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1846245 Charles James Miller C/O Recro Pharma, Inc.
1 E Uwchlan Ave, Suite 112
Exton PA 19341
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-17 1,000 $1.69 27,923 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct